Moleculin Biotech, Inc. (MBRX)
NASDAQ·Healthcare·Biotechnology
$2.54
+0.00%
Mkt Cap $2.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 20, 2026 | — | — | — | -$7.77 | $2.61 | +133.59% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$5.00 | -$3.25 | +35.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$9.75 | -$12.25 | -25.64% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$17.75 | -$17.25 | +2.82% | — | — |
| Q1 2025 Mar 21, 2025 | — | — | — | -$1.54 | -$0.37 | +75.97% | — | — |
| Q4 2024 Nov 11, 2024 | — | — | — | -$2.44 | -$2.85 | -16.80% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$52.50 | -$55.75 | -6.19% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$89.75 | -$50.50 | +43.73% | — | — |
| Q1 2024 Mar 22, 2024 | — | — | — | -$3.05 | -$5.02 | -64.59% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$78.71 | -$71.21 | +9.53% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$104.95 | -$74.96 | +28.58% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$93.70 | -$104.95 | -12.01% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$104.95 | -$89.96 | +14.28% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$101.20 | -$112.44 | -11.11% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$93.70 | -$89.96 | +3.99% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$78.71 | -$89.96 | -14.29% | — | — |
| Q1 2022 Mar 25, 2022 | — | — | — | -$78.71 | -$63.72 | +19.04% | — | — |
| Q4 2021 Nov 11, 2021 | — | — | — | -$74.96 | -$56.22 | +25.00% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$74.96 | -$71.21 | +5.00% | — | — |
| Q2 2021 May 12, 2021 | $49 | — | — | -$97.45 | -$74.96 | +23.08% | — | — |